Page 55 Cite

Suggested Citation:"Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23530.

×

Appendix A

Workshop Agenda

APRIL 9, 2015

Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials

8:30–8:45 a.m.

Welcome and Overview

Victor Dzau, M.D.

President, National Academy of Medicine

Antonia M. Villarruel, Ph.D.

Roundtable Chair

Dean, College of Nursing, University of Pennsylvania

Jonca Bull, M.D.

Director, Office of Minority Health, U.S. Food and Drug Administration (FDA)

8:45–10:15 a.m.

Panel 1: Historical Perspectives and Context

Moderator: Chazeman Jackson, Ph.D., Office of Minority Health, U.S. Department of Health and Human Services

Amelie Ramirez, Dr.P.H.

University of Texas Health Sciences Center

Page 56 Cite

Suggested Citation:"Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23530.

×

	Otis Brawley, M.D., F.A.C.P. American Cancer Society Charles Rotimi, Ph.D. National Institutes of Health (NIH)
10:15–10:30 a.m.	BREAK
10:30 a.m.–12:00 p.m.	Panel 2: Scientific Issues: Clinically Meaningful Inclusion Moderator: Allan Goldberg, M.D., Merck & Co., Inc. Objectives: Study design adequacy for subpopulation analyses and outcomes Inclusion/exclusion criteria that results in unintentional bias against some populations Research designs that are relevant to diverse populations and subpopulation analyses Dave Hickam, M.D., M.P.H. Patient-Centered Outcomes Research Institute Jocelyn Ulrich, M.P.H., R.A.C. Pharmaceutical Research and Manufacturers of America Carol Horowitz, M.D., M.P.H. Mount Sinai
12:00–1:00 p.m.	LUNCH
1:00–2:30 p.m.	Panel 3: Recruitment and Retention Issues: Patient, Provider, Institutional, and System Barriers Moderator: Deidra Crews, M.D., S.C.M., Gilbert S. Omenn Anniversary Fellow of the Institute of Medicine, Johns Hopkins University Objectives: Describe barriers to research, including culturally incongruent research designs, inaccessibility of clinical trials locations to diverse communities, inadequate outreach, and legal status Community engagement in clinical trials research

Page 57 Cite

Suggested Citation:"Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23530.

×

	Connie Ulrich, Ph.D., R.N., F.A.A.N. University of Pennsylvania Jonathan Ellen, M.D. Johns Hopkins All Children’s Hospital Moon Chen, Ph.D., M.P.H. University of California, Davis
2:30–2:45 p.m.	BREAK
2:45–4:15 p.m.	Panel 4: Best Practices and Policy Recommendations Moderator: Francisco García, Pima County Health Department Karen Kim, M.D. University of Chicago Teshia Solomon, Ph.D. University of Arizona Sandra E. Brooks, M.D., M.B.A. University of Louisville
4:15–4:45 p.m.	Concluding Reflections Toni Villarruel, Ph.D., R.N., F.A.A.N. Roundtable Chair Barbara Buch, M.D. FDA
4:45 p.m.	ADJOURN

Page 58 Cite

Suggested Citation:"Appendix A: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23530.

×